Risitano, Antonio M <br/><br/>
Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab.  [electronic resource] 

 -  Blood  Apr 2009 
 - 4094-100 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2008-11-189944  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--immunology<br/>Antibodies, Monoclonal, Humanized<br/>Cell Survival<br/>Complement C3--metabolism<br/>Erythrocytes--metabolism<br/>Female<br/>Flow Cytometry<br/>Hemoglobinuria, Paroxysmal--immunology<br/>Humans<br/>Immunotherapy<br/>Male